Skip to content
Home
About
ABOUT
About Overview
Leadership
Science
Pipeline
Patient & Caregiver Resources
Resources
Clinical Trials & Expanded Access Policy
Spinal Cord Injury
Investors
Investors
Stock Information
Financial Information
Corporate Governance
News Releases
Events & Presentations
Analyst Coverage
In The Media
Contact Us
Home
About
ABOUT
About Overview
Leadership
Science
Pipeline
Patient & Caregiver Resources
Resources
Clinical Trials & Expanded Access Policy
Spinal Cord Injury
Investors
Investors
Stock Information
Financial Information
Corporate Governance
News Releases
Events & Presentations
Analyst Coverage
In The Media
Contact Us
Home
About
ABOUT
About Overview
Leadership
Science
Pipeline
Patient & Caregiver Resources
Resources
Clinical Trials & Expanded Access Policy
Spinal Cord Injury
Investors
Investors
Stock Information
Financial Information
Corporate Governance
News Releases
Events & Presentations
Analyst Coverage
In The Media
Contact Us
Home
About
ABOUT
About Overview
Leadership
Science
Pipeline
Patient & Caregiver Resources
Resources
Clinical Trials & Expanded Access Policy
Spinal Cord Injury
Investors
Investors
Stock Information
Financial Information
Corporate Governance
News Releases
Events & Presentations
Analyst Coverage
In The Media
Contact Us
Financial Information
Latest Financial Results
Quarter Ended June 30, 2026
Financial Statements
MD&A
Past Financial Results
2026
Quarter Ended March 31, 2026
Financial Statements
MD&A
2025
Year Ended December 31, 2025
Financial Statements
MD&A
Quarter Ended September 30, 2025
Financial Statements
MD&A
Quarter Ended June 30, 2025
Financial Statements
MD&A
Quarter Ended March 31, 2025
Financial Statements
MD&A
2024
Year Ended December 31, 2024
Financial Statements
MD&A
Quarter Ended September 30, 2024
Financial Statements
MD&A
Quarter Ended June 30, 2024
Financial Statements
MD&A
Quarter Ended March 31, 2024
Financial Statements
MD&A
2023
Year Ended December 31, 2023
Financial Statements
MD&A
Quarter Ended September 30, 2023
Financial Statements
MD&A
Quarter Ended June 30, 2023
Financial Statements
MD&A
Quarter Ended March 31, 2023
Financial Statements
MD&A
2022
Year Ended December 31, 2022
Financial Statements
MD&A
Quarter Ended September 30, 2022
Financial Statements
MD&A
Quarter Ended June 30, 2022
Financial Statements
MD&A
Quarter Ended March 31, 2022
Financial Statements
MD&A
2021
Year Ended December 31, 2021
Financial Statements
MD&A
Quarter Ended September 30, 2021
Financial Statements
MD&A
Quarter Ended June 30, 2021
Financial Statements
MD&A
Quarter Ended March 31, 2021
Financial Statements
MD&A
2020
Year Ended December 31, 2020
Financial Statements
MD&A
Quarter Ended September 30, 2020
Financial Statements
MD&A
Quarter Ended June 30, 2020
Financial Statements
MD&A
Quarter Ended March 31, 2020
Financial Statements
MD&A
2019
Year Ended December 31, 2019
Financial Statements
MD&A
Quarter Ended September 30, 2019
Financial Statements
MD&A
Quarter Ended June 30, 2019
Financial Statements
MD&A
Quarter Ended March 31, 2019
Financial Statements
MD&A
2018
Year Ended December 31, 2018
Financial Statements
MD&A
Quarter Ended September 30, 2018
Financial Statements
MD&A
Quarter Ended June 30, 2018
Financial Statements
MD&A
Additional Documents
SEDAR Regulatory Filings
The Future of Neurorepair Has Begun.
Be Part of What Comes Next.
CONTACT US
